Adaia Albasanz‐Puig
- Oncology
- Epidemiology
- Clinical Biochemistry top 5%
- Immunology
- Molecular Medicine top 10%
- Co-authors
- Carlota GudiolJordi CarratalàJacqueline MurrayErrol S. WijelathGuillermo CuervoJúlia Laporte-AmargósZhao DongCarolina García‐Vidal
- Topics
- Neutropenia and Cancer Infections (4 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)Cytomegalovirus and herpesvirus research (3 papers)
- Partner nations
- SpainUnited StatesPalestinian Territory
In The Last Decade
Adaia Albasanz‐Puig
14 papers receiving 319 citations
Peers
Comparison fields: 5 of 65
- Oncology 178
- Epidemiology 100
- Clinical Biochemistry 76
- Immunology 53
- Molecular Medicine 51
Countries citing papers authored by Adaia Albasanz‐Puig
This map shows the geographic impact of Adaia Albasanz‐Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adaia Albasanz‐Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adaia Albasanz‐Puig more than expected).
Fields of papers citing papers by Adaia Albasanz‐Puig
This network shows the impact of papers produced by Adaia Albasanz‐Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adaia Albasanz‐Puig. The network helps show where Adaia Albasanz‐Puig may publish in the future.
Co-authorship network of co-authors of Adaia Albasanz‐Puig
This figure shows the co-authorship network connecting the top 25 collaborators of Adaia Albasanz‐Puig. A scholar is included among the top collaborators of Adaia Albasanz‐Puig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adaia Albasanz‐Puig. Adaia Albasanz‐Puig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 30 | |
| 4 | 3 | |
| 5 | 52 | |
| 6 | 7 | |
| 7 | 8 | |
| 8 | 8 | |
| 9 | 101 | |
| 10 | 15 | |
| 11 | 11 | |
| 12 | 24 | |
| 13 | 23 | |
| 14 | 41 |
About Adaia Albasanz‐Puig
Adaia Albasanz‐Puig is a scholar working on Oncology, Molecular Medicine and Virology, having authored 14 papers that have together received 325 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (28 citations), Clinical Biochemistry (76 citations) and Molecular Medicine (51 citations). Adaia Albasanz‐Puig has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include Carlota Gudiol, Jordi Carratalà, Jacqueline Murray, Errol S. Wijelath, Guillermo Cuervo, Júlia Laporte-Amargós, Zhao Dong, Carolina García‐Vidal, Pedro Puerta‐Alcalde and Àlex Soriano. Their work appears in journals such as Neurology, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.